Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Return on Sales (2022 - 2026)

Envoy Medical's Return on Sales history spans 5 years, with the latest figure at 1.53% for Q1 2026.

  • On a quarterly basis, Return on Sales fell 31.0% to 1.53% in Q1 2026 year-over-year; TTM through Mar 2026 was 1.03%, a 6.0% decrease, with the full-year FY2025 number at 0.99%, down 10.0% from a year prior.
  • Return on Sales hit 1.53% in Q1 2026 for Envoy Medical, down from 0.85% in the prior quarter.
  • Over the last five years, Return on Sales for COCH hit a ceiling of 1.0% in Q3 2022 and a floor of 1.53% in Q1 2026.
  • Historically, Return on Sales has averaged 0.7% across 5 years, with a median of 0.83% in 2024.
  • Biggest five-year swings in Return on Sales: plummeted -142bps in 2023 and later surged 32bps in 2025.
  • Tracing COCH's Return on Sales over 5 years: stood at 0.84% in 2022, then grew by 16bps to 0.71% in 2023, then tumbled by -66bps to 1.17% in 2024, then rose by 28bps to 0.85% in 2025, then tumbled by -79bps to 1.53% in 2026.
  • Business Quant data shows Return on Sales for COCH at 1.53% in Q1 2026, 0.85% in Q4 2025, and 1.47% in Q3 2025.